Culture

Getting under your skin: Molecular research builds new understanding of skin regeneration

As the air continues to dry and temperatures drop, the yearly battle against dry hands and skin has officially begun. New research from Northwestern University has found new evidence deep within the skin about the mechanisms controlling skin repair and renewal.

Skin's barrier function gives it the unique ability to fight winter woes and retain water for our bodies. The outer layer of the skin, the epidermis, is constantly turning over to replace dead or damaged cells, creating new cells to reinforce the barrier function and heal damage. The gene regulatory mechanisms that control epidermis turnover remain incompletely understood.

"Every month we're covered with a new layer of epidermis," said Northwestern's Xiaomin Bao, who led the study. "The next question is what does that process involve?"

The paper will be published Jan. 19 in the journal Nature Communications.

Bao is an assistant professor of molecular biosciences in the Weinberg College of Arts and Sciences with a joint appointment in the Department of Dermatology at the Feinberg School of Medicine.

Genetic 'junk'

The scientific community has developed a wide breadth of knowledge about proteins, the workhorses of various cellular activities. However, proteins are only encoded by less than 2% of the human genome. Many mysteries remain about the nature of introns, non-coding segments of DNA that make up 24% of the human genome.

Despite the general belief that introns are nothing but "genetic junk," they actually play critical roles in modulating RNA transcription throughout a tissue's lifespan. RNA transcription is the first step of gene expression, in which the information from DNA is copied into RNA, which is then subsequently used as template for synthesizing proteins to drive the specific function of a cell. Depending on where transcription terminates -- in an intron or at the end of a gene -- an epidermal stem cell will either remain a stem cell or become a specified cell barrier function. Bao said while it's well-know that transcription ends at the end of a gene, her lab's research found conflicting data.

"We found a lot of sites where transcription terminates--not just at the end of a gene, but often within an intron in the middle of a gene," Bao said. "Even the same genes may have different transcription termination patterns in epidermal stem cells versus terminally differentiated cells."

The finding may apply to many more self-renewing regenerative systems in the human body. Future research could have implications on carcinoma research.

Technology critical to discovery of phenomenon

Skin cells are gaining popularity with researchers in part due to their regenerative properties and readiness to grow in cultures. This allows researchers to apply a variety of state-of-the-art technologies. By growing skin cells and regenerating skin tissue in a petri dish, the Bao Lab can experiment with this fast-growing tissue to determine molecular mechanisms and regulatory elements within DNA.

"Technology development is a key driver that allowed us to uncover this new phenomenon," Bao said.

The team used a novel genomic technique that precisely maps where transcription stops. The integration of proteomic approaches identified RNA-binding proteins that read specific regulatory sequences in the introns. The team further leveraged CRISPR technology to delete genomic sequences in the intron, which provided direct evidence demonstrating the essential roles of introns in modulating gene expression.

Before this research, mechanisms involving introns to govern the switch between a skin stem cell and a terminally differential state (for example, a cell that participates in forming a skin barrier), were unknown. Most studies ignored introns, despite them accounting for 10 to 20 times more sequences than the protein-coding regions (exons) in the human genome.

The study shows that different genes may involve different sets of RNA-binding proteins to recognize the regulatory sequences in their introns. These RNA-binding proteins help maturing RNA "decide" whether to cut transcription early, or ignore termination sites within an intron during differentiation due to changes in protein availability.

"We are only beginning to appreciate the roles of intron in human health and diseases," Bao said.

Results of the study could have wider impacts because, according to Bao, the processes regulating skin cells are almost definitely not restricted to skin cells. Future research on other systems, including other epithelial tissues, will likely uncover similar patterns.

"We are very hopeful that what we've found is the first step to knowing what we have ignored in the past," Bao said. "With the contribution of the non-coding genome and in this case, particularly the contribution of introns, this information is revelatory to gene expression. My students also want to know more about the RNA binding proteins that provide specificity in governing which site to use to terminate transcription."

Credit: 
Northwestern University

Stop global roll out of 5G networks until safety is confirmed, urges expert

We should err on the side of caution and stop the global roll out of 5G (fifth generation) telecoms networks until we are certain this technology is completely safe, urges an expert in an opinion piece published online in the Journal of Epidemiology & Community Health.

There are no health concerns about 5G and COVID-19, despite what conspiracy theorists have suggested.

But the transmitter density required for 5G means that more people will be exposed to radio frequency electromagnetic fields (RF-EMFs), and at levels that emerging evidence suggests, are potentially harmful to health, argues Professor John William Frank, Usher Institute, University of Edinburgh.

The advent of 5G technology has been hailed by governments and certain vested interests as transformative, promising clear economic and lifestyle benefits, through massively boosting wireless and mobile connectivity at home, work, school and in the community, he says.

But it has become the subject of fierce controversy, fuelled by four key areas of scientific uncertainty and concern.

The lack of clarity about precisely what technology is included in 5G; and a growing but far from comprehensive body of laboratory research indicating the biologically disruptive potential of RF-EMFs

An almost total lack (as yet) of high quality epidemiological studies of the impact on human health from 5G EMF exposure

Mounting epidemiological evidence of such effects from previous generations of RF-EMF exposure at lower levels

Persistent allegations that some national telecomms regulatory authorities haven't based their RF-EMF safety policies on the latest science, amid potential conflicts of interest

5G uses much higher frequency (3 to 300GHz) radio waves than in the past and it makes use of very new--and relatively unevaluated, in terms of safety--supportive technology to enable this higher data transmission capacity, points out Professor Frank.

Its inherent fragility means that transmission boosting 'cell' antennae are generally required every 100-300 m--which is far more spatially dense than the transmission masts required for older 2G, 3G and 4G technology, using lower frequency waves, he says.

A dense transmission network is also required to achieve the 'everywhere/anytime' connectivity promised by 5G developers.

Existing 4G systems can service up to 4000 radio frequency-using devices per square kilometre; 5G systems will connect up to one million devices per square kilometre--greatly increasing the speed of data transfer (by a factor of 10) and the volume of data transmitted (by a factor of 1000), he explains.

While several major reviews of the existing evidence on the potential health harms of 5G have been published over the past decade, these have been of "varying scientific quality," suggests Professor Frank.

And they have not stopped the clamour from "a growing number of engineers, scientists, and doctors internationally...calling on governments to raise their safety standards for RF-EMFs, commission more and better research, and hold off on further increases in public exposure, pending clearer evidence of safety," he writes.

Permitted maximum safety limits for RF-EMF exposure vary considerably around the world, he points out.

What's more, '5G systems' is not a consistently defined term, comprising quite different specific technologies and components.

"It is highly likely that each of these many forms of transmission causes somewhat different biological effects--making sound, comprehensive and up-to-date research on those effects virtually impossible," he explains.

Recent reviews of lab data on RF-EMFs indicate that exposures can produce wide-ranging effects, including reproductive, fetal, oncological, neuropsychiatric, skin, eye and immunological. But there is absolutely no evidence whatsoever to suggest that it is implicated in the spread of COVID-19, as some conspiracy theorists have suggested, he emphasises.

"There are knowledgeable commentators' reports on the web debunking this theory, and no respectable scientist or publication has backed it," he says, adding: "the theory that 5G and related EMFs have contributed to the pandemic is baseless."

But for the current 5G roll-out, there's a sound basis for invoking 'the precautionary principle' because of significant doubts about the safety of a new and potentially widespread human exposure, which should be reason enough "to call a moratorium on that exposure, pending adequate scientific investigation of its suspected adverse health effects," he says.

There is no compelling public health or safety rationale for the rapid deployment of 5G, he insists. The main gains being promised are either economic, and then possibly for some more than for others, or related to increased consumer convenience, he suggests.

"Until we know more about what we are getting into, from a health and ecological point of view, those putative gains need to wait," he concludes.

Credit: 
BMJ Group

A 'super-puff' planet like no other

image: Artistic rendition of the exoplanet WASP-107b and its star, WASP-107. Some of the star's light streams through the exoplanet's extended gas layer.

Image: 
ESA/Hubble, NASA, M. Kornmesser.

The core mass of the giant exoplanet WASP-107b is much lower than what was thought necessary to build up the immense gas envelope surrounding giant planets like Jupiter and Saturn, astronomers at Université de Montréal have found.

This intriguing discovery by Ph.D. student Caroline Piaulet of UdeM's Institute for Research on Exoplanets (iREx) suggests that gas-giant planets form a lot more easily than previously believed.

Piaulet is part of the groundbreaking research team of UdeM astrophysics professor Björn Benneke that in 2019 announced the first detection of water on an exoplanet located in its star's habitable zone.

Published today in the Astronomical Journal with colleagues in Canada, the U.S., Germany and Japan, the new analysis of WASP-107b's internal structure "has big implications," said Benneke.

"This work addresses the very foundations of how giant planets can form and grow," he said. "It provides concrete proof that massive accretion of a gas envelope can be triggered for cores that are much less massive than previously thought."

As big as Jupiter but 10 times lighter

WASP-107b was first detected in 2017 around WASP-107, a star about 212 light years from Earth in the Virgo constellation. The planet is very close to its star -- over 16 times closer than the Earth is to the Sun. As big as Jupiter but 10 times lighter, WASP-107b is one of the least dense exoplanets known: a type that astrophysicists have dubbed "super-puff" or "cotton-candy" planets.

Piaulet and her team first used observations of WASP-107b obtained at the Keck Observatory in Hawai'i to assess its mass more accurately. They used the radial velocity method, which allows scientists to determine a planet's mass by observing the wobbling motion of its host star due to the planet's gravitational pull. They concluded that the mass of WASP-107b is about one tenth that of Jupiter, or about 30 times that of Earth.

The team then did an analysis to determine the planet's most likely internal structure. They came to a surprising conclusion: with such a low density, the planet must have a solid core of no more than four times the mass of the Earth. This means that more than 85 percent of its mass is included in the thick layer of gas that surrounds this core. By comparison, Neptune, which has a similar mass to WASP-107b, only has 5 to 15 percent of its total mass in its gas layer.

"We had a lot of questions about WASP-107b," said Piaulet. "How could a planet of such low density form? And how did it keep its huge layer of gas from escaping, especially given the planet's close proximity to its star?

"This motivated us to do a thorough analysis to determine its formation history."

A gas giant in the making

Planets form in the disc of dust and gas that surrounds a young star called a protoplanetary disc. Classical models of gas-giant planet formation are based on Jupiter and Saturn. In these, a solid core at least 10 times more massive than the Earth is needed to accumulate a large amount of gas before the disc dissipates.

Without a massive core, gas-giant planets were not thought able to cross the critical threshold necessary to build up and retain their large gas envelopes.

How then do explain the existence of WASP-107b, which has a much less massive core? McGill University professor and iREx member Eve Lee, a world-renowned expert on super-puff planets like WASP-107b, has several hypotheses.

"For WASP-107b, the most plausible scenario is that the planet formed far away from the star, where the gas in the disc is cold enough that gas accretion can occur very quickly," she said. "The planet was later able to migrate to its current position, either through interactions with the disc or with other planets in the system."

Discovery of a second planet, WASP-107c

The Keck observations of the WASP-107 system cover a much longer period of time than previous studies have, allowing the UdeM-led research team to make an additional discovery: the existence of a second planet, WASP-107c, with a mass of about one-third that of Jupiter, considerably more than WASP-107b's.

WASP-107c is also much farther from the central star; it takes three years to complete one orbit around it, compared to only 5.7 days for WASP-107b. Also interesting: the eccentricity of this second planet is high, meaning its trajectory around its star is more oval than circular.

"WASP-107c has in some respects kept the memory of what happened in its system," said Piaulet. "Its great eccentricity hints at a rather chaotic past, with interactions between the planets which could have led to significant displacements, like the one suspected for WASP-107b."

Several more questions

Beyond its formation history, there are still many mysteries surrounding WASP-107b. Studies of the planet's atmosphere with the Hubble Space Telescope published in 2018 revealed one surprise: it contains very little methane.

"That's strange, because for this type of planet, methane should be abundant," said Piaulet. "We're now reanalysing Hubble's observations with the new mass of the planet to see how it will affect the results, and to examine what mechanisms might explain the destruction of methane."

The young researcher plans to continue studying WASP-107b, hopefully with the James Webb Space Telescope set to launch in 2021, which will provide a much more precise idea of the composition of the planet's atmosphere.

"Exoplanets like WASP-107b that have no analogue in our Solar System allow us to better understand the mechanisms of planet formation in general and the resulting variety of exoplanets," she said. "It motivates us to study them in great detail."

Credit: 
University of Montreal

Successive governments' approach to obesity policies has destined them to fail

Successive governments' approach to obesity policies has destined them to fail, say researchers.

Government obesity policies in England over the past three decades have largely failed because of problems with implementation, lack of learning from past successes or failures, and a reliance on trying to persuade individuals to change their behaviour rather than tackling unhealthy environments. This is the conclusion of new research by a team at the University of Cambridge funded by the NIHR School for Public Health Research.

The researchers say their findings may help to explain why, after nearly thirty years of government obesity policies, obesity prevalence in England has not fallen and substantial inequalities persist. According to a report by NHS Digital in May 2020, 67% of men and 60% of women live with overweight or obesity, including 26% of men and 29% of women who suffer clinical obesity. More than a quarter of children aged two to 15 years live with obesity or overweight and the gap between the least and most deprived children is growing.

Successive governments have tried to tackle the obesity problem: in research published today in The Milbank Quarterly, Dolly Theis and Martin White in the Centre for Diet and Activity Research (CEDAR) at the University of Cambridge identified 14 government-led obesity strategies in England from 1992-2020. They analysed these strategies - which contained 689 wide-ranging policies - to determine whether they have been fit for purpose in terms of their strategic focus, content, basis in theory and evidence, and implementation viability.

Seven of the strategies were broad public health strategies containing obesity as well as non-obesity policies such as on tobacco smoking and food safety. The other seven contained only obesity-related policies, such as on diet and/or physical activity. Twelve of the fourteen strategies contained obesity reduction targets. However, only five of these were specific, numerical targets rather than statements such as 'aim to reduce obesity'.

Theis said: "In almost 30 years, successive UK governments have proposed hundreds of wide-ranging policies to tackle obesity in England, but these are yet to have an impact on levels of obesity or reduce inequality. Many of these policies have largely been flawed from the outset and proposed in ways that make them difficult to implement. What's more, there's been a fairly consistent failure to learn from past mistakes. Governments appear more likely to publish another strategy containing the same, recycled policies than to implement policies already proposed.

"If we were to produce a report card, overall we might only give them 4 out of 10: could do much better."

Theis and White identified seven criteria necessary for effective implementation, but found that only 8% of policies fulfilled all seven criteria, while the largest proportion of policies (29%) did not fulfil a single one of the criteria. Fewer than a quarter (24%) included a monitoring or evaluation plan, just 19% cited any supporting scientific evidence, and less than one in ten (9%) included details of likely costs or an allocated budget.

The lack of such basic information as the cost of implementing policies was highlighted in a recent National Audit Office report on the UK Government's approach to tackling childhood obesity in England, which found that the Department of Health and Social Care did not know how much central government spent tackling childhood obesity.

"No matter how well-intended and evidence-informed a policy, if it is nebulously proposed without a clear plan or targets it makes implementation difficult and it is unlikely the policy will be deemed successful," added Theis. "One might legitimately ask, what is the purpose of proposing policies at all if they are unlikely to be implemented?"

Thirteen of the 14 strategies explicitly recognised the need to reduce health inequality, including one strategy that was fully focused on reducing inequality in health. Yet the researchers say that only 19% of policies proposed were likely to be effective in reducing inequalities because of the measures proposed.

UK governments have to date largely favoured a less interventionist approach to reducing obesity, regardless of political party, prioritising provision of information to the public in their obesity strategies, rather than more directly shaping the choices available to individuals in their living environments through regulation or taxes. The researchers say that governments may have avoided a more deterrence-based, interventionist approach for fear of being perceived as 'nannying' - or because they lacked knowledge about what more interventionist measures are likely to be effective.

There is, however, evidence to suggest that policymaking is changing. Even though the current UK government still favours a less interventionist approach, more recent strategies have contained some fiscal and regulatory policies, such as banning price promotions of unhealthy products, banning unhealthy food advertisements and the Soft Drinks Industry Levy. This may be because the government has come under increasing pressure and recognises that previous approaches have not been effective, that more interventionist approaches are increasingly acceptable to the public, and because evidence to support regulatory approaches is mounting.

The researchers found little attempt to evaluate the strategies and build on their successes and failures. As a result, many policies proposed were similar or identical over multiple years, often with no reference to their presence in a previous strategy. Only one strategy (Saving Lives, published in 1999) commissioned a formal independent evaluation of the previous government's strategy.

"Until recently, there seems to have been an aversion to conducting high quality, independent evaluations, perhaps because they risk demonstrating failure as well as success," added White. "But this limits a government's ability to learn lessons from past policies. This may be potentially compounded by the often relatively short timescales for putting together a strategy or implementing policies.

"Governments need to accompany policy proposals with information that ensures they can be successfully implemented, and with built-in evaluation plans and time frames. Important progress has been made with commissioning evaluations in the last three years. But, we also need to see policies framed in ways that make them readily implementable. We also need to see a continued move away from interventions that rely on individual's changing their diet and activity, and towards policies that change the environments that encourage people to overeat and to be sedentary in the first place."

Living with obesity or excess weight is associated with long-term physical, psychological and social problems. Related health problems, such as type-2 diabetes, cardiovascular disease and cancers, are estimated to cost NHS England at least £6.1 billion per year and the overall cost of obesity to wider society in England is estimated to be £27 billion per year. The COVID-19 pandemic has brought to light additional risks for people living with obesity, such as an increased risk of hospitalisation and more serious disease.

Credit: 
University of Cambridge

Inexpensive battery charges rapidly for electric vehicles, reduces range anxiety

image: A thermally modulated battery for mass-market electric vehicles without range anxiety and with unsurpassed safety, low cost, and containing no cobalt, is being developed by a team of Penn State engineers.

Image: 
Chao-Yang Wang's lab, Penn State

Range anxiety, the fear of running out of power before being able to recharge an electric vehicle, may be a thing of the past, according to a team of Penn State engineers who are looking at lithium iron phosphate batteries that have a range of 250 miles with the ability to charge in 10 minutes.

"We developed a pretty clever battery for mass-market electric vehicles with cost parity with combustion engine vehicles," said Chao-Yang Wang, William E. Diefenderfer Chair of mechanical engineering, professor of chemical engineering and professor of materials science and engineering, and director of the Electrochemical Engine Center at Penn State. "There is no more range anxiety and this battery is affordable."

The researchers also say that the battery should be good for 2 million miles in its lifetime.

They report today (Jan. 18) in Nature Energy that the key to long-life and rapid recharging is the battery's ability to quickly heat up to 140 degrees Fahrenheit, for charge and discharge, and then cool down when the battery is not working.

"The very fast charge allows us to downsize the battery without incurring range anxiety," said Wang.

The battery uses a self-heating approach previously developed in Wang's center. The self-heating battery uses a thin nickel foil with one end attached to the negative terminal and the other extending outside the cell to create a third terminal. Once electrons flow it rapidly heats up the nickel foil through resistance heating and warm the inside of the battery. Once the battery's internal temperature is 140 degrees F, the switch opens and the battery is ready for rapid charge or discharge.

Wang's team modeled this battery using existing technologies and innovative approaches. They suggest that using this self-heating method, they can use low-cost materials for the battery's cathode and anode and a safe, low-voltage electrolyte. The cathode is thermally stable, lithium iron phosphate, which does not contain any of the expensive and critical materials like cobalt. The anode is made of very large particle graphite, a safe, light and inexpensive material.

Because of the self-heating, the researchers said they do not have to worry about uneven deposition of lithium on the anode, which can cause lithium spikes that are dangerous.

"This battery has reduced weight, volume and cost," said Wang. "I am very happy that we finally found a battery that will benefit the mainstream consumer mass market."

According to Wang, these smaller batteries can produce a large amount of power upon heating -- 40 kilowatt hours and 300 kilowatts of power. An electric vehicle with this battery could go from zero to 60 miles per hour in 3 seconds and would drive like a Porsche, he said.

"This is how we are going to change the environment and not contribute to just the luxury cars," said Wang. "Let everyone afford electric vehicles."

Credit: 
Penn State

New discovery in breast cancer treatment

image: Androgen counterbalances estrogen-driven breast cancer

Image: 
University of Adelaide

Researchers at the University of Adelaide have found new evidence about the positive role of androgens in breast cancer treatment with immediate implications for women with estrogen receptor-driven metastatic disease.

Published today in Nature Medicine, the international study conducted in collaboration with the Garvan Institute of Medical Research, looked at the role of androgens - commonly thought of as male sex hormones but also found at lower levels in women - as a potential treatment for estrogen receptor positive breast cancer.

Watch a video explainer about the new study at - https://youtu.be/NYalzv4C35U

In normal breast development, estrogen stimulates and androgen inhibits growth at puberty and throughout adult life. Abnormal estrogen activity is responsible for the majority of breast cancers, but the role of androgen activity in this disease has been controversial.

Androgens were historically used to treat breast cancer, but knowledge of hormone receptors in breast tissue was rudimentary at the time and the treatment's efficacy misunderstood. Androgen therapy was discontinued due to virilising side effects and the advent of anti-estrogenic endocrine therapies.

While endocrine therapy is standard-of-care for estrogen receptor positive breast cancer, resistance to these drugs are the major cause of breast cancer mortality.

Professor Wayne Tilley, Director of the Dame Roma Mitchell Cancer Research Laboratories, and Associate Professor Theresa Hickey, Head of the Breast Cancer Group, who led the study say the need for alternative treatment strategies has renewed interest in androgen therapy for breast cancer.

However, previous studies had produced conflicting evidence on how best to therapeutically target the androgen receptor for treatment of breast cancer, which caused widespread confusion and hampered clinical application.

Using cell-line and patient-derived models, a global team, including researchers at the University of Adelaide and the Garvan Institute, demonstrated that androgen receptor activation by natural androgen or a new androgenic drug had potent anti-tumour activity in all estrogen receptor positive breast cancers, even those resistant to current standard-of-care treatments. In contrast, androgen receptor inhibitors had no effect.

"This work has immediate implications for women with metastatic estrogen receptor positive breast cancer, including those resistant to current forms of endocrine therapy,'' said Associate Professor Theresa Hickey.

Professor Tilley added: "We provide compelling new experimental evidence that androgen receptor stimulating drugs can be more effective than existing (e.g. Tamoxifen) or new (e.g. Palbociclib) standard-of-care treatments and, in the case of the latter, can be combined to enhance growth inhibition.

Moreover, currently available selective androgen receptor activating agents lack the undesirable side effects of natural androgens, and can confer benefits in women including promotion of bone, muscle and mental health.

Associate Professor Elgene Lim, a breast oncologist and Head of the Connie Johnson Breast Cancer Research Lab at the Garvan Institute, said: "The new insights from this study should clarify the widespread confusion over the role of the androgen receptor in estrogen receptor driven breast cancer. Given the efficacy of this treatment strategy at multiple stages of disease in our study, we hope to translate these findings into clinical trials as a new class of endocrine therapy for breast cancer."

Dr Stephen Birrell, a breast cancer specialist and pioneer in androgens and women's health who was part of the Adelaide based team, pointed out that this seminal finding has application beyond the treatment of breast cancer, including breast cancer prevention and treatment of other disorders also driven by estrogen.

Chloe Marshall, 33, has a breast cancer recurrence while pregnant with her second child. She said that endocrine therapy has terrible side effects and there was an urgent need for better options to prevent and treat breast cancer recurrence.

"I was diagnosed with a hormone positive breast cancer in July 2017 and subsequently found out I carried the BRACA gene,'' she said.

"I underwent a double mastectomy and neo adjuvant chemotherapy followed by two years of hormone suppressive treatment. The hormone suppressive treatment that I experienced was one of the hardest parts of having cancer. The impact it has on your mind/life/body is incredibly challenging.

"Now, three years later, I find myself with a recurrent cancer while 25 weeks pregnant. The thought of having hormone suppressive treatment for a further five to ten years is overwhelming.

"I think this study will help patients like myself have hope that there is another answer to life after the cancer diagnosis."

Credit: 
University of Adelaide

How cells move and don't get stuck

image: Cancer cells moving on glycoproteine strips: These strips act like splints, which allow to control and to study the movement of the cells better.

Image: 
Rädler Lab, Ludwig Maximilians Universität München

Cell velocity, or how fast a cell moves, is known to depend on how sticky the surface is beneath it, but the precise mechanisms of this relationship have remained elusive for decades. Now, researchers from the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) and Ludwig Maximilians Universität München (LMU) have figured out the precise mechanics and developed a mathematical model capturing the forces involved in cell movement. The findings, reported in the journal Proceedings of the National Academy of Sciences (PNAS), provide new insight for developmental biology and potential cancer treatment.

Cell movement is a fundamental process, especially critical during development when cells differentiate into their target cell type and then move to the correct tissue. Cells also move to repair wounds, while cancer cells crawl to the nearest blood vessel to spread to other parts of the body.

"The mathematical model we developed can now be used by researchers to predict how different cells will behave on various substrates," says Professor Martin Falcke, who heads MDC's Mathematical Cell Physiology Lab and co-led the research. "Understanding these basic movements in precise detail could provide new targets to interrupt tumor metastasis."

Teaming up to pin down

The finding comes thanks to experimental physicists at LMU teaming up with theoretical physicists at MDC. The experimentalists, led by Professor Joachim Rädler, tracked how quickly more than 15,000 cancer cells moved along narrow lanes on a sticky surface, where the stickiness alternated between low and high. This allowed them to observe what happens as the cell transitions between stickiness levels, which is more representative of the dynamic environment inside the body.

Then, Falcke and Behnam Amiri, co-first paper author and Ph.D. student in Falcke's lab, used the large dataset to develop a mathematical equation that captures the elements shaping cell motility.

"Previous mathematical models trying to explain cell migration and motility are very specific, they only work for one feature or cell type," Amiri says. "What we tried to do here is keep it as simple and general as possible."

The approach worked even better than expected: the model matched the data gathered at LMU and held true for measurements about several other cell types taken over the past 30 years. "This is exciting," Falcke says. "It's rare that you find a theory explaining such a large spectrum of experimental results."

Friction is key

When a cell moves, it pushes out its membrane in the direction of travel, expanding an internal network of actin filaments as it goes, and then peels off its back end. How fast this happens depends on adhesion bonds that form between the cell and the surface beneath it. When there are no bonds, the cell can hardly move because the actin network doesn't have anything to push off against. The reason is friction: "When you are on ice skates you cannot push a car, only when there is enough friction between your shoes and the ground can you push a car," Falcke says.

As the number of bonds increase, creating more friction, the cell can generate more force and move faster, until the point when it is so sticky, it becomes much harder to pull off the back end, slowing the cell down again.

Slow, but not stuck

The researchers investigated what happens when the front and rear ends of the cell experience different levels of stickiness. They were particularly curious to figure out what happens when it is stickier under the back end of the cell than the front, because that is when the cell could potentially get stuck, unable to generate enough force to pull off the back end.

This might have been the case if the adhesion bonds were more like screws, holding the cell to the substrate. At first, Falcke and Amiri included this type of "elastic" force in their model, but the equation only worked with friction forces.

"For me, the most challenging part was to wrap my mind around this mechanism working only with friction forces," Falcke says, because there is nothing for the cell to firmly latch onto. But it is the friction-like forces that allow the cell to keep moving, even when bonds are stronger in the back than the front, slowly peeling itself off like scotch tape. "Even if you pull just a little with a weak force, you are still able to peel the tape off - very slowly, but it comes off," Falcke says. "This is how the cell keeps itself from getting stuck."

The team is now investigating how cells move in two dimensions, including how they make hard right and left turns, and U-turns.

Credit: 
Max Delbrück Center for Molecular Medicine in the Helmholtz Association

Synthesis of potent antibiotic follows unusual chemical pathway

image: The synthesis of the potent antibiotic thiostrepton uses a radical SAM protein TsrM, whose crystal structure is shown at left while bound to an iron-sulfur cluster and cobalamin. New images of this crystal structure allowed researchers from Penn State to infer the chemical steps during the antibiotic's synthesis (right), as a methyl group moves from a molecule called S-adenosyl-L-methionine (SAM) to the cobalamin in TsrM to the substrate tryptophan.

Image: 
Booker Lab, Penn State

UNIVERSITY PARK, Pa. -- Images of a protein involved in creating a potent antibiotic reveal the unusual first steps of the antibiotic's synthesis. The improved understanding of the chemistry behind this process, detailed in a new study led by Penn State chemists, could allow researchers to adapt this and similar compounds for use in human medicine.

"The antibiotic thiostrepton is very potent against Gram-positive pathogens and can even target certain breast cancer cells in culture," said Squire Booker, a biochemist at Penn State and investigator with the Howard Hughes Medical Institute. "While it has been used topically in veterinary medicine, so far it has been ineffective in humans because it is poorly absorbed. We studied the first steps in thiostrepton's biosynthesis in hopes of eventually being able to hijack certain processes and make analogs of the molecule that might have better medicinal properties. Importantly, this reaction is found in the biosynthesis of numerous other antibiotics, and so the work has the potential to be far reaching."

The first step in thiostrepton's synthesis involves a process called methylation. A molecular tag called methyl group, which is important in many biological processes, is added to a molecule of tryptophan, the reaction's substrate. One of the major systems for methylating compounds that are not particularly reactive, like tryptophan, involves a class of enzymes called radical SAM proteins.

"Radical SAM proteins usually use an iron-sulfur cluster to cleave a molecule called S-adenosyl-L-methionine (SAM), producing a "free radical" or an unpaired electron that helps move the reaction forward," said Hayley Knox, a graduate student in chemistry at Penn State and first author of the paper. "The one exception that we know about so far is the protein involved in the biosynthesis of thiostrepton, called TsrM. We wanted to understand why TsrM doesn't do radical chemistry, so we used an imaging technique called X-ray crystallography to investigate its structure at several stages throughout its reaction."

In all radical SAM proteins characterized to date, SAM binds directly to the iron-sulfur cluster, which helps to fragment the molecule to produce the free radical. However, the researchers found that the site where SAM would typically bind is blocked in TsrM.

"This is completely different from any other radical SAM protein," said Booker. "Instead, the portion of SAM that binds to the cluster associates with the tryptophan substrate and plays a key role in the reaction, in what is called substrate-assisted catalysis."

The researchers present their results in an article appearing Jan. 18 in the journal Nature Chemistry.

In solving the structure, the researchers were able to infer the chemical steps during the first part of thiostrepton's biosynthesis, when tryptophan is methylated. In short, the methyl group from SAM transfers to a part of TsrM called cobalamin. Then, with the help of an additional SAM molecule, the methyl group transfers to tryptophan, regenerating free cobalamin and producing the methylated substrate, which is required for the next steps in synthesizing the antibiotic.

"Cobalamin is the strongest nucleophile in nature, which means it is highly reactive," said Knox. "But the substrate tryptophan is weakly nucleophilic, so a big question is how cobalamin could ever be displaced. We found that an arginine residue sits under the cobalamin and destabilizes the methyl-cobalamin, allowing tryptophan to displace cobalamin and become methylated."

Next the researchers plan to study other cobalamin-dependent radical SAM proteins to see if they operate in similar ways. Ultimately, they hope to find or create analogs of thiostrepton that can be used in human medicine.

"TsrM is clearly unique in terms of known cobalamin-dependent radical SAM proteins and radical SAM proteins in general," said Booker. "But there are hundreds of thousands of unique sequences of radical SAM enzymes, and we still don't know what most of them do. As we continue to study these proteins, we may be in store for many more surprises."

Credit: 
Penn State

Lasers & molecular tethers create perfectly patterned platforms for tissue engineering

image: Top view of two collagen hydrogels that researchers decorated with immobilized mCherry proteins, which glow red under fluorescent light. The team scanned near-infrared lasers in the shapes of a monster (left) and Seattle's Space Needle (right) to create these patterns. Black regions were not scanned with the laser, and so the mCherry protein did not adhere to those portions of the hydrogel. Scale bar is 50 micrometers.

Image: 
Batalov et al., PNAS, 2021

Imagine going to a surgeon to have a diseased or injured organ switched out for a fully functional, laboratory-grown replacement. This remains science fiction and not reality because researchers today struggle to organize cells into the complex 3D arrangements that our bodies can master on their own.

There are two major hurdles to overcome on the road to laboratory-grown organs and tissues. The first is to use a biologically compatible 3D scaffold in which cells can grow. The second is to decorate that scaffold with biochemical messages in the correct configuration to trigger the formation of the desired organ or tissue.

In a major step toward transforming this hope into reality, researchers at the University of Washington have developed a technique to modify naturally occurring biological polymers with protein-based biochemical messages that affect cell behavior. Their approach, published the week of Jan. 18 in the Proceedings of the National Academy of Sciences, uses a near-infrared laser to trigger chemical adhesion of protein messages to a scaffold made from biological polymers such as collagen, a connective tissue found throughout our bodies.

Mammalian cells responded as expected to the adhered protein signals within the 3D scaffold, according to senior author Cole DeForest, a UW associate professor of chemical engineering and of bioengineering. The proteins on these biological scaffolds triggered changes to messaging pathways within the cells that affect cell growth, signaling and other behaviors.

These methods could form the basis of biologically based scaffolds that might one day make functional laboratory-grown tissues a reality, said DeForest, who is also a faculty member with the UW Molecular Engineering and Sciences Institute and the UW Institute for Stem Cell and Regenerative Medicine.

"This approach provides us with the opportunities we've been waiting for to exert greater control over cell function and fate in naturally derived biomaterials -- not just in three-dimensional space but also over time," said DeForest. "Moreover, it makes use of exceptionally precise photochemistries that can be controlled in 4D while uniquely preserving protein function and bioactivity."

DeForest's colleagues on this project are lead author Ivan Batalov, a former UW postdoctoral researcher in chemical engineering and bioengineering, and co-author Kelly Stevens, a UW assistant professor of bioengineering and of laboratory medicine and pathology.

Their method is a first for the field, spatially controlling cell function inside naturally occurring biological materials as opposed to those that are synthetically derived. Several research groups, including DeForest's, have developed light-based methods to modify synthetic scaffolds with protein signals. But natural biological polymers can be a more attractive scaffold for tissue engineering because they innately possess biochemical characteristics that cells rely on for structure, communication and other purposes.

"A natural biomaterial like collagen inherently includes many of the same signaling cues as those found in native tissue," said DeForest. "In many cases, these types of materials keep cells 'happier' by providing them with similar signals to those they would encounter in the body."

They worked with two types of biological polymers: collagen and fibrin, a protein involved in blood clotting. They assembled each into fluid-filled scaffolds known as hydrogels.

The signals that the team added to the hydrogels are proteins, one of the main messengers for cells. Proteins come in many forms, all with their own unique chemical properties. As a result, the researchers designed their system to employ a universal mechanism to attach proteins to a hydrogel -- the binding between two chemical groups, an alkoxyamine and an aldehyde. Prior to hydrogel assembly, they decorated the collagen or fibrin precursors with alkoxyamine groups, all physically blocked with a "cage" to prevent the alkoxyamines from reacting prematurely. The cage can be removed with ultraviolet light or a near-infrared laser.

Using methods previously developed in DeForest's laboratory, the researchers also installed aldehyde groups to one end of the proteins they wanted to attach to the hydrogels. They then combined the aldehyde-bearing proteins with the alkoxyamine-coated hydrogels, and used a brief pulse of light to remove the cage covering the alkoxyamine. The exposed alkoxyamine readily reacted with the aldehyde group on the proteins, tethering them within the hydrogel. The team used masks with patterns cut into them, as well as changes to the laser scan geometries, to create intricate patterns of protein arrangements in the hydrogel -- including an old UW logo, Seattle's Space Needle, a monster and the 3D layout of the human heart.

The tethered proteins were fully functional, delivering desired signals to cells. Rat liver cells -- when loaded onto collagen hydrogels bearing a protein called EGF, which promotes cell growth -- showed signs of DNA replication and cell division. In a separate experiment, the researchers decorated a fibrin hydrogel with patterns of a protein called Delta-1, which activates a specific pathway in cells called Notch signaling. When they introduced human bone cancer cells into the hydrogel, cells in the Delta-1-patterned regions activated Notch signaling, while cells in areas without Delta-1 did not.

These experiments with multiple biological scaffolds and protein signals indicate that their approach could work for almost any type of protein signal and biomaterial system, DeForest said.

"Now we can start to create hydrogel scaffolds with many different signals, utilizing our understanding of cell signaling in response to specific protein combinations to modulate critical biological function in time and space," he added.

With more-complex signals loaded on to hydrogels, scientists could then try to control stem cell differentiation, a key step in turning science fiction into science fact.

Credit: 
University of Washington

Mount Sinai researchers build models using machine learning technique to enhance predictions of COVID-19 outcomes

This release has been removed upon request of the submitting institution. Please contact Stacy Anderson, Stacy.Anderson@mountsinai.org for more information.

Credit: 
The Mount Sinai Hospital / Mount Sinai School of Medicine

Eliminating microplastics in wastewater directly at the source

image: Electro-analytical system used to identify appropriate electrodes for anodic oxidation processes.

Image: 
INRS

A research team from the Institut national de la recherche scientifique (INRS) has developed a process for the electrolytic treatment of wastewater that degrades microplastics at the source. The results of this research have been published in the Environmental Pollution journal.

Wastewater can carry high concentrations of microplastics into the environment. These small particles of less than 5 mm can come from our clothes, usually as microfibers. Professor Patrick Drogui, who led the study, points out there are currently no established degradation methods to handle this contaminant during wastewater treatment. Some techniques already exist, but they often involve physical separation as a means of filtering pollutants. These technologies do not degrade them, which requires additional work to manage the separated particles.

Therefore, the research team decided to degrade the particles by electrolytic oxidation, a process not requiring the addition of chemicals. "Using electrodes, we generate hydroxyl radicals (* OH) to attack microplastics. This process is environmentally friendly because it breaks them down into CO2 and water molecules, which are non-toxic to the ecosystem," explains the researcher. The electrodes used in this process are more expensive than iron or steel electrodes, which degrade over time, but can be reused for several years.

An effective treatment

Professor Drogui envisions the use of this technology at the exit of commercial laundries, a potential source of microplastics release into the environment. "When this commercial laundry water arrives at the wastewater treatment plant, it is mixed with large quantities of water, the pollutants are diluted and therefore more difficult to degrade. Conversely, by acting at the source, i.e., at the laundry, the concentration of microplastics is higher (per litre of water), thus more accessible for electrolytic degradation," explains the specialist in electrotechnology and water treatment.

Laboratory tests conducted on water artificially contaminated with polystyrene showed a degradation efficiency of 89%. The team plans to move on to experiments on real water. "Real water contains other materials that can affect the degradation process, such as carbonates and phosphates, which can trap radicals and reduce the performance of the oxidation process," says Professor Drogui, scientific director of the Laboratory of Environmental Electrotechnologies and Oxidative Processes (LEEPO).

If the technology demonstrates its effectiveness on real commercial laundry water, the research group intends to conduct a study to determine the cost of treatment and the adaptation of the technology to treat larger quantities of wastewater. Within a few years, the technology could be implemented in laundry facilities.

Credit: 
Institut national de la recherche scientifique - INRS

Students returning home may have caused 9,400 secondary COVID-19 infections across UK

A student infected with COVID-19 returning home from university for Christmas would, on average, have infected just less than one other household member with the virus, according to a new model devised by mathematicians at Cardiff University and published in Health Systems.

Professor Paul Harper and colleagues defined an equation to predict the number of secondary household infections using variables for prevalence of the virus, the probability of secondary transmission, the number of household occupants and the total number of students returning home.

The model predicts that each infected student allowed to return home would produce, on average, 0.94 secondary infections.

"With the potential movement of over 1 million UK students for the Christmas vacation, even a modest 1% infection level (meaning 10 in 1,000 students are infected, perhaps many of them without symptoms at the time of travel) would equate to 9,400 new secondary household cases across the country," says Professor Harper.

As the study does not consider transmission to the students' wider home communities or include the journey home - which may give rise to a larger number of cases, particularly if public transport is taken - the numbers are a lower bound on the likely impact of transmissions and new cases.

However, although the indicative levels of secondary infections are potentially very large, multiple strategies can be adopted to help reduce the number of students taking Covid-19 home, the authors say. These include strongly advising students not to mix in the days leading up to departure, implementing staggered departure times and facilitating mass testing of students before they head home.

The authors have provided computer code and an online app (http://bit.ly/Secondary_infections_app) to allow anyone to rerun and adapt the simulations. "The code and app are quick to run with a focus on accessibility so that a user can rapidly change the input probabilities to suit their data, thereby generating their own results based on localised parameters," the authors say.

Their results have been presented to the Welsh Government and have informed policy in relation to the two-week firebreak in Wales in October/November and for the forthcoming vacation. The data has also been communicated across the governments of England, Scotland and Northern Ireland.

Credit: 
Taylor & Francis Group

Changing diets -- not less physical activity -- may best explain childhood obesity crisis

image: Traditional Shuar lunch items

Image: 
Samuel Urlacher

Variation in consumption of market-acquired foods outside of the traditional diet -- but not in total calories burned daily -- is reliably related to indigenous Amazonian children's body fat, according to a Baylor University study that offers insight into the global obesity epidemic.

"The importance of a poor diet versus low energy expenditure on the development of childhood obesity remains unclear," said Samuel Urlacher, Ph.D., assistant professor of anthropology at Baylor University, CIFAR Azrieli Global Scholar and lead author of the study. "Using gold-standard measures of energy expenditure, we show that relatively lean, rural forager-horticulturalist children in the Amazon spend approximately the same total number of calories each day as their much fatter peri-urban counterparts and, notably, even the same number of calories each day as children living in the industrialized United States.

"Variation in things like habitual physical activity and immune activity have no detectable impact on children's daily energy expenditure in our sample," he said.

The study -- "Childhood Daily Energy Expenditure Does Not Decrease with Market Integration and Is Not Related to Adiposity in Amazonia" -- is published in The Journal of Nutrition, the American Society for Nutrition's flagship journal, and was funded by the National Science Foundation.

"That initial result alone is exciting in confirming our prior finding of relative stability in children's daily energy expenditure across different lifestyles and environments," Urlacher said. "But our study goes further. It shows that Amazonian children who eat more high-calorie market foods -- but not those who spend fewer calories every day -- consistently have more body fat.

"Together, these findings support the view that change in diet is likely the dominant factor driving the global rise in childhood obesity, particularly in the context of rapid urbanization and market integration in low- and middle-income countries," he said.

The global rate of overweight/obesity among school-age children and adolescents has risen from 4% in 1975 to 18% as of 2016, according to the NCD Risk Factor Collaboration. That reflects a major global health crisis. Children who are overweight/obese often remain so into adulthood. They have shorter life expectancy and a greater lifetime risk of developing noncommunicable diseases, including Type 2 diabetes and heart disease.

"While the most rapid rise in childhood overweight and obesity is now in rural areas and in low- and middle-income countries, few previous studies have actually measured, rather than simply estimated, children's energy expenditure in these settings to identify the cause of energy imbalance," Urlacher said.

To investigate school-age children's diets and energy expenditure during early market integration and transition to overweight/obesity, Urlacher and co-researchers* collected data among 43 rural and 34 peri-urban Shuar children in Amazonian Ecuador. The Shuar are a large indigenous population of around 50,000. Children in the rural study sample live in a geographically isolated region and rely predominantly on a subsistence-based lifestyle based on hunting, fishing, foraging and small-scale horticulture. In contrast, children in the peri-urban study sample live in a regional market center with access to roads, a hospital, stores, restaurants and other market amenities.

To measure variation in market integration among households, researchers collected information on things such as income and access to running water. They also measured children's physical activity using wearable devices and immune activity by measuring biomarkers in minimally invasive finger-prick blood samples. Most importantly, the researchers measured children's daily energy expenditure using the "doubly labeled water" stable isotope-tracking method and children's resting energy expenditure using respirometry - both participant-friendly, gold-standard techniques.

The study found that:

Peri-urban children average 65% more body fat than rural children, with more than a third of peri-urban children classified as overweight compared to zero rural children.

Peri-urban children eat more than four times as many market-acquired items as rural children.

Peri-urban and rural children have similar levels of physical activity.

Peri-urban children spend 108 calories per day less than rural children while at rest. This is related in part to 16-47% lower levels of immune activity.

Measures of market integration, immune activity and physical activity have no detectable impact on children's overall energy expenditure, with peri-urban and rural children spending roughly the same number of calories.

Variation in consumption of market foods, but not in daily energy expenditure, is related to children's body fat.

The study is the first to measure children's energy expenditure across market integration in a single population simultaneously with measures of diet, physical activity and immune activity. The finding of no effect of market integration on measured daily energy expenditure is consistent with previous reports among adults and infants, Urlacher said. It also supports an evolutionary model of childhood energy constraint and allocation trade-offs described in detail by the researchers in their 2019 paper published in the journal Science Advances.

By measuring multiple aspects of the energy balance equation simultaneously, the researchers believe that their findings provide persuasive evidence for a likely primary role of changing dietary intake, rather than reduced daily energy expenditure, in driving the rise in childhood obesity in many populations.

"Our findings are in line with a growing body of research pointing toward poor diet being the most important factor underlying the development of childhood obesity," Urlacher said. "Exercise is absolutely still a critical part of this equation and is essential for living a healthy life, but diet increasingly appears to be most directly related to children's adiposity and long-term energy balance."

The researchers plan to advance this work by collecting longitudinal data to assess individual children's lifetime development of obesity and cardiometabolic diseases. They also plan to collect more detailed dietary data and analyze a wider range of lifestyle and biological factors to identify causal pathways. Central to these efforts is determining how to best apply findings to improve children's health in low- and middle-income countries.

"Childhood obesity is a complex problem that must be addressed on many different levels, ranging from the biological to the environmental, economic, social and political," Urlacher said.

"At the end of the day, everyone working on this problem wants the same thing: to improve children's lifelong health and well-being. We hope that this work can ultimately contribute to that effort, particularly for the Shuar whose generosity and partnership made this research possible."

Credit: 
Baylor University

Better diet and glucose uptake in the brain lead to longer life in fruit flies

image: Glucose uptake in brain neurons decreases with age (left), Increasing glucose uptake in brain neurons counteracts aging (middle), Increasing glucose uptake in brain neurons plus dietary restriction further extends lifespan (light).

Image: 
Tokyo Metropolitan University

Tokyo, Japan - Researchers from Tokyo Metropolitan University have discovered that fruit flies with genetic modifications to enhance glucose uptake have significantly longer lifespans. Looking at the brain cells of aging flies, they found that better glucose uptake compensates for age-related deterioration in motor functions, and led to longer life. The effect was more pronounced when coupled with dietary restrictions. This suggests healthier eating plus improved glucose uptake in the brain might lead to enhanced lifespans.

The brain is a particularly power-hungry part of our bodies, consuming 20% of the oxygen we take in and 25% of the glucose. That's why it's so important that it can stay powered, using the glucose to produce adenosine triphosphate (ATP), the "energy courier" of the body. This chemical process, known as glycolysis, happens in both the intracellular fluid and a part of cells known as the mitochondria. But as we get older, our brain cells become less adept at making ATP, something that broadly correlates with less glucose availability. That might suggest that more food for more glucose might actually be a good thing. On the other hand, it is known that a healthier diet actually leads to longer life. Unravelling the mystery surrounding these two contradictory pieces of knowledge might lead to a better understanding of healthier, longer lifespans.

A team led by Associate Professor Kanae Ando studied this problem using Drosophila fruit flies. Firstly, they confirmed that brain cells in older flies tended to have lower levels of ATP, and lower uptake of glucose. They specifically tied this down to lower amounts of the enzymes needed for glycolysis. To counteract this effect, they genetically modified flies to produce more of a glucose-transporting protein called hGut3. Amazingly, this increase in glucose uptake was all that was required to significantly improve the amount of ATP in cells. More specifically, they found that more hGut3 led to less decrease in the production of the enzymes, counteracting the decline with age. Though this did not lead to an improvement in age-related damage to mitochondria, they also suffered less deterioration in locomotor functions.

But that's not all. In a further twist, the team put the flies with enhanced glucose uptake under dietary restrictions, to see how the effects interact. Now, the flies had even longer lifespans. Curiously, the increased glucose uptake did not actually improve the levels of glucose in brain cells. The results point to the importance of not just how much glucose there is, but how efficiently it is used once taken into cells to make the energy the brain needs.

Though the anti-aging benefits of a restricted diet have been shown in many species, the team were able to combine this with improved glucose uptake to leverage the benefits of both for even longer lifespans in a model organism. Further study may provide vital clues to how we might keep our brains healthier for longer.

Credit: 
Tokyo Metropolitan University

The COVID-19 pandemic in brazil has overwhelmed its health systems

The spread of COVID-19 in Brazil overwhelmed the health systems in all the country's regions, particularly in areas where they were already fragile, according to a collaborative effort involving the Barcelona Institute for Global Health (ISGlobal), an institution supported by the "la Caixa" Foundation, the University of Sao Paulo, the Catholic University of Rio de Janeiro, the D'Or Institute of Research and Education and the Oswaldo Cruz Foundation. The findings, published in The Lancet Respiratory Medicine, reveal that a large percentage of COVID-19 patients that were hospitalised in Brazil required intensive care and respiratory support, and many did not survive.

The COVID-19 pandemic has put an enormous strain on healthcare systems across the world by increasing the demand for healthcare professionals and the need for beds in intensive care units and respiratory support such as ventilators. However, the mortality rate among confirmed cases has greatly varied between countries and this is in great part due to differences in the capacity and preparedness of their health systems.

"To date, there is very limited data on the mortality of patients hospitalised with COVID-19 or on how the health systems have coped with the pandemic in low- and middle-income countries" explains Otavio Ranzani, ISGlobal researcher and first author of the study. Brazil, for example, is an upper middle-income country with a unified health system for its 210 million inhabitants. However, the country's unique health system has been undermined by recent economic and political crises and there is great heterogeneity across different regions of the country.

Ranzani and his colleagues used data from a nationwide surveillance system to evaluate the characteristics of the first 250,000 patients admitted to hospital with COVID-19 in Brazil, whether they required intensive care or respiratory support, and how many of them died. They also analysed the impact of COVID-19 on healthcare resources and in-hospital mortality across the country's five big regions.

The analysis shows that almost half (47%) of the 254,288 patients admitted to hospital with COVID-19 were under 60 years-old. The in-hospital mortality rate was high (38%) and rose to 60% among those admitted to the intensive care unit (ICU) and to 80% for those who were mechanically ventilated. Although COVID-19 overwhelmed the health system in all five regions, hospital admissions and mortality were considerably higher in the North and Northeast regions at the beginning of the pandemic (for example, 31% of patients aged under 60 died in hospitals in the Northeast versus 15% in the South).

"These regional differences in mortality reflect differences in access to better health care that already existed before the pandemic", explains Fernando Bozza, study coordinator and researcher at the National Institute of Infectious Disease. "This means that COVID-19 not only disproportionately affects the most vulnerable patients but also the most fragile health systems", he adds. "Brazil's health system is one of the largest across the globe to provide care to everyone free of charge and has a solid tradition in the surveillance of infectious diseases. However, COVID-19 overwhelmed the system's capacity", says Ranzani.

The authors conclude that the high mortality observed in hospitals underlines the need for improving the structure and the organisation of the health system, particularly in low- and middle-income countries. This implies increasing available resources - from equipment and consumables, to ICU beds and trained healthcare staff.

Credit: 
Barcelona Institute for Global Health (ISGlobal)